AMPK-α2 is involved in exercise training-induced adaptations in insulinstimulated metabolism in skeletal muscle following high-fat diet

Journal of Applied Physiology

Volumn 117, Issue 8, 2014, Pages 869-879

  Abbott, Marcia J ^a,b   Turcotte, Lorraine P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHAPMAN UNIVERSITY   (United States)

Author keywords

AMPK; Exercise training; Fatty acid metabolism; Glucose uptake; Insulin resistance

Indexed keywords

AMPK ALPHA2 SUBUNIT, MOUSE; CARNITINE PALMITOYLTRANSFERASE; CD36 ANTIGEN; CITRATE SYNTHASE; GLUCOSE BLOOD LEVEL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 9; PALMITIC ACID DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE 1;

ADAPTATION; ANIMAL; ANIMAL EXPERIMENT; C57BL MOUSE; GLUCOSE BLOOD LEVEL; HINDLIMB; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLISM; MOUSE; OBESITY; OXIDATION REDUCTION REACTION; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADAPTATION, PHYSIOLOGICAL; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIGENS, CD36; BLOOD GLUCOSE; CARNITINE O-PALMITOYLTRANSFERASE; CITRATE (SI)-SYNTHASE; DIET, HIGH-FAT; HINDLIMB; INSULIN; INSULIN RESISTANCE; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; PALMITATES; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL;

EID: 84908565581     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01380.2013     Document Type: Article

References (50)

1. Abbott MJ, Bogachus LD, Turcotte LP. AMPKα2 deficiency uncovers time dependency in the regulation of contraction-induced palmitate and glucose uptake in mouse muscle. J Appl Physiol 111: 125-134, 2011.
2. Abbott MJ, Constantinescu S, Turcotte LP. AMP-activated protein kinaseα2 is an essential signal in the regulation of insulin-stimulated fatty acid uptake in control-fed and high-fat-fed mice. Exp Physiol 97: 603-617, 2012.
3. Abbott MJ, Edelman AM, Turcotte LP. CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. Am J Physiol Regul Integr Comp Physiol 297: R1724-R1732, 2009.
4. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55: 2277-2285, 2006.
5. Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJF, Dyck DJ. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291: E99-E107, 2006.
6. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458: 1056-1060, 2009.
7. Cantó C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR, Auwerx J. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11: 213-219, 2010.
8. Carling D, Thornton C, Woods A, Sanders MJ. AMP-activated protein kinase: new regulation, new roles? Biochem J 445: 11-27, 2012.
9. Chabi B, Adhihetty PJ, O'Leary MFN, Menzies KJ, Hood DA. Relationship between Sirt1 expression and mitochondrial proteins during conditions of chronic muscle use and disuse. J Appl Physiol 107: 1730-1735, 2009.
10. Durante PE, Mustard KJ, Park SH, Winder WW, Hardie DG. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am J Physiol Endocrinol Metab 283: E178-E186, 2002.
11. Eckel RH, Alberti K, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 375: 181-183, 2010.
12. Fisher JS, Gao J, Han DH, Holloszy JO, Nolte LA. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 282: E18-E23, 2002.
13. Frøsig C, Jørgensen SB, Hardie DG, Richter EA, Wojtaszewski JFP. 5=-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. Am J Physiol Endocrinol Metab 286: E411-E417, 2004.
14. Fujii N, Ho RC, Manabe Y, Jessen N, Toyoda T, Holland WL, Summers SA, Hirshman MF, Goodyear LJ. Ablation of AMP-activated protein kinaseα2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes 57: 2958-2966, 2008.
15. Hawley JA, Zierath JR. Integration of metabolic and mitogenic signal transduction in skeletal muscle. Exerc Sport Sci Rev 32: 4-8, 2004.
16. Hegarty BD, Cooney GJ, Kraegen EW, Furler SM. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51: 1477-1484, 2002.
17. Hegarty BD, Turner N, Cooney GJ, Kraegen EW. Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase. Acta Physiol 196: 129-145, 2009.
18. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
19. Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, Lan F, Walsh K, Wierzbicki M, Verbeuren TJ, Cohen RA, Zang M. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283: 20015-20026, 2008.
20. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, Houmard JA. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284: E741-E747, 2003.
21. Ivy JL, Sherman WM, Cutler CL, Katz AL. Exercise and diet reduce muscle insulin resistance in obese Zucker rat. Am J Physiol Endocrinol Metab 251: E299-E305, 1986.
22. Jeppesen J, Albers PH, Rose AJ, Birk JB, Schjerling P, Dzamko N, Steinberg GR, Kiens B. Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent. J Lipid Res 52: 699-711, 2011.
23. Jørgensen SB, Treebak JT, Viollet B, Schjerling P, Vaulont S, Wojtaszewski JFP, Richter EA. Role of AMPKα2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am J Physiol Endocrinol Metab 292: E331-E339, 2007.
24. Keung W, Ussher JR, Jaswal JS, Raubenheimer M, Lam VHM, Wagg CS, Lopaschuk GD. Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice. Diabetes 62: 711-720, 2013.
25. Kiens B, Essen-Gustavsson B, Christensen NJ, Saltin B. Skeletal muscle substrate utilization during submaximal exercise in man: effect of endurance training. J Physiol 469: 459-478, 1993.
26. Kraegen EW, Storlien LH, Jenkins AB, James DE. Chronic exercise compensates for insulin resistance induced by a high-fat diet in rats. Am J Physiol Endocrinol Metab 256: E242-E249, 1989.
27. Lee-Young RS, Griffee SR, Lynes SE, Bracy DP, Ayala JE, McGuinness OP, Wasserman DH. Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. J Biol Chem 284: 23925-23934, 2009.
28. Liu Y, Wan Q, Guan Q, Gao L, Zhao J. High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle. Biochem Biophys Res Commun 339: 701-707, 2006.
29. Merrill GF, Kurth EJ, Rasmussen BB, Winder WW. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle. J Appl Physiol 85: 1909-1914, 1998.
30. Mole P, Holloszy J. Exercise-induced increase in the capacity of skeletal muscle to oxidize palmitate. Proc Soc Exp Biol Med 134: 789-792, 1970.
31. Mu J, Brozinick JT, Valladares O, Bucan M, Birnbaum MJ. A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094, 2001.
32. Nielsen JN, Mustard KJW, Graham DA, Yu H, MacDonald CS, Pilegaard H, Goodyear LJ, Hardie DG, Richter EA, Wojtaszewski JFP. 5=-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631-641, 2003.
33. Raney MA, Turcotte LP. Regulation of contraction-induced FA uptake and oxidation by AMPK and ERK1/2 is intensity dependent in rodent muscle. Am J Physiol Endocrinol Metab 291: E1220-E1227, 2006.
34. Raney MA, Turcotte LP. Evidence for the regulation of contractioninduced fatty acid oxidation via extracellular signal-regulated kinase 1/2 activation independent of changes in fatty acid uptake. Metabolism 56: 1192-1200, 2007.
35. Röckl KSC, Hirshman MF, Brandauer J, Fujii N, Witters LA, Goodyear LJ. Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 56: 2062-2069, 2007.
36. Romero-Calvo I, Ocón B, Martínez-Moya P, Suárez MD, Zarzuelo A, Martínez-Augustin O, de Medina FS. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401: 318-20, 2010.
37. Ruderman NB, Houghton CRS, Hems R. Evaulation of the isolated perfused rat hindquarter for the study of muscle metabolism. Biochem Journal1 124: 639-651, 1971.
38. Ruderman NB, Julia Xu X, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 298: E751-E760, 2010.
39. Smith BK, Bonen A, Holloway GP. A dual mechanism of action for skeletal muscle FAT/CD36 during exercise. Exerc Sport Sci Rev 40: 211-217, 2012.
40. Sriwijitkamol A, Ivy JL, Christ-Roberts C, DeFronzo RA, Mandarino LJ, Musi N. LKB1-AMPK signaling in muscle from obese insulinresistant Zucker rats and effects of training. Am J Physiol Endocrinol Metab 290: E925-E932, 2006.
41. Thomson DM, Winder WW. AMP-activated protein kinase control of fat metabolism in skeletal muscle. Acta Physiol 196: 147-154, 2009.
42. Thyfault JP, Cree MG, Zheng D, Zwetsloot JJ, Tapscott EB, Koves TR, Ilkayeva O, Wolfe RR, Muoio DM, Dohm GL. Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. Am J Physiol Cell Physiol 292: C729-C739, 2007.
43. Todd MK, Watt MJ, Le J, Hevener AL, Turcotte LP. Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance. Am J Physiol Endocrinol Metab 292: E485-E493, 2007.
44. Turcotte LP, Raney MA, Todd MK. ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle. Acta Physiol Scand 184: 131-139, 2005.
45. Turcotte LP, Swenberger JR, Tucker MZ, Yee AJ. Training-induced elevation in FABPPM is associated with increased palmitate use in contracting muscle. J Appl Physiol 87: 285-293, 1999.
46. Turcotte LP, Swenberger JR, Zavitz Tucker M, Yee AJ. Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats. Diabetes 50: 1389-1396, 2001.
47. Turcotte LP. Lipid metabolism during exercise. In: Exercise Metabolism, edited by Hargreaves M, Spriet LL. Champaign, IL: Human Kinetics, 2006, p. 105-136.
48. Viollet B, Horman S, Leclerc J, Lantier L, Foretz M, Billaud M, Giri S, Andreelli F. AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol 45: 276-295, 2010.
49. Warburton DER, Nicol CW, Bredin SSD. Health benefits of physical activity: the evidence. Can Med Assoc J 174: 801-809, 2006.
50. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, Saiu P, Howell SA, Aasland R, Martin SR, Carling D, Gamblin SJ. Structure of mammalian AMPK and its regulation by ADP. Nature 472: 230-233, 2011.